"Ethyl-pyridine-2-Ona, Syk inhibitors substituted by Indazol or Pirazolo [4,3-C] pyridine； intermediates； pharmaceutical components containing these compounds； and compounds used in the treatment of flammability, autoimmunity and other diseases". PCT
DAHMANN GEORG,KLICIC JASNA,HOFFMANN MATTHIAS,SCOTT JOHN,LAMB DAVID JAMES,MACCARTHY CLIVE,NAPIER SPENCER,PARRISH KAREN,SWANTEK FITZGERALD JENNIFER L.,WALKER EDWARD
申请号：
CL2016001963
公开号：
CL2016001963A1
申请日:
2016.08.04
申请国别(地区):
CL
年份:
2016
代理人:
摘要：
The compounds for which the application is directed are derived from Indazol or Pirazolo [4,3-C] Piridina and are replaced by ethyl-Pirrolidin-2-Ona (SYK inhibitor)； intermediate compounds； pharmaceutical ingredients including these compounds； and uses for treating inflammation and self-immunity. E, among other things.LA SOLICITUD SE REFIERE A COMPUESTOS DERIVADOS DE INDAZOL O PIRAZOLO[4,3-C]PIRIDINA SUSTITUIDOS CON UN GRUPO ETILOXI-PIRROLIDIN-2-ONA, INHIBIDORES SYK； COMPUESTOS INTERMEDIARIOS, A UNA COMPOSICIÓN FARMACÉUTICA QUE LOS COMPRENDE Y A SU USO EN EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS, AUTOINMUNE, ENTRE OTRAS.
